William Dezarn to Brachytherapy
This is a "connection" page, showing publications William Dezarn has written about Brachytherapy.
Connection Strength
2.071
-
Dezarn WA. Regarding "PET/CT Imaging Characteristics After Radioembolization of Hepatic Metastasis from Breast Cancer". Cardiovasc Intervent Radiol. 2020 03; 43(3):520.
Score: 0.689
-
Dezarn WA, Cessna JT, DeWerd LA, Feng W, Gates VL, Halama J, Kennedy AS, Nag S, Sarfaraz M, Sehgal V, Selwyn R, Stabin MG, Thomadsen BR, Williams LE, Salem R. Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies. Med Phys. 2011 Aug; 38(8):4824-45.
Score: 0.384
-
Kennedy AS, Nutting C, Jakobs T, Cianni R, Notarianni E, Ofer A, Beny A, Dezarn WA. A first report of radioembolization for hepatic metastases from ocular melanoma. Cancer Invest. 2009 Jul; 27(6):682-90.
Score: 0.333
-
Dezarn WA. Quality assurance issues for therapeutic application of radioactive microspheres. Int J Radiat Oncol Biol Phys. 2008; 71(1 Suppl):S147-51.
Score: 0.300
-
Dezarn WA, Kennedy AS. Resin 90Y microsphere activity measurements for liver brachytherapy. Med Phys. 2007 Jun; 34(6):1896-900.
Score: 0.288
-
Kennedy AS, Dezarn WA, McNeillie P, Coldwell D, Nutting C, Carter D, Murthy R, Rose S, Warner RR, Liu D, Palmedo H, Overton C, Jones B, Salem R. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients. Am J Clin Oncol. 2008 Jun; 31(3):271-9.
Score: 0.077